changes in lifestyle
Participants in the pulmonary blood pressure conference held by the Saudi Consultative Group concluded a group shot of the doctors participating in the Pulmonary Blood Pressure Conference Jeddah: Al-Watan 2011-05-13 12:00 AM for high blood pressure in the pulmonary artery, and the Saudi Society for Lung Diseases, in cooperation with the company Bayer Health Care, the pharmaceutical industry, and the European Society for Hypertension, noted that pulmonary hypertension is a chronic, progressive and personal disease that causes debility, has major impacts on social life, and requires major lifestyle changes.
The participants in the conference workshops, hosted by Dubai last week, discussed the latest information and forms of the disease, which was defined as a fatal disease, symbolized by the symbol (PH), and it affects about 15 people out of every million people.
The consultant pulmonologist, head of the Saudi Consultative Group for Pulmonary Artery Hypertension, Prof. Dr. Magdi Idris, reviewed the seriousness of pulmonary hypertension, stressing that it is a life-threatening condition that raises the pressure of the lung arteries higher than the normal range, which causes a severe decrease in the patient The ability to withstand physical stress, and that the disease is often misdiagnosed or delayed.
The number of symptoms of pulmonary hypertension is the most common, stressing that it includes shortness of breath, especially when doing physical activity, fatigue, dizziness, and fainting, and all of them worsen with stress, stressing that the condition is dangerous and life-threatening, and may lead to heart failure or death.
He added, "According to the division of the World Health Organization, there are five different types of pulmonary hypertension, divided on the basis of the pathogenesis of pulmonary hypertension, and although the causes of pulmonary hypertension disease are still unknown, it is accompanied by other diseases, such as heart disease." Congenital, chronic liver disease, connective tissue disease, and HIV infection "AIDS", and in rare cases it can be hereditary. "
The head of the Saudi Consultative Group for Pulmonary Hypertension said, "Pulmonary hypertension is a dangerous condition that requires early and accurate diagnosis and prompt treatment. It is often diagnosed between the ages of 40 - 60 years, with its spread among young women in an unjustified manner."
For his part, a consultant pulmonologist at the Military Hospital in Riyadh, Prof. Dr. Saleh Al-Damas, explained that pulmonary hypertension is a chronic and advanced disease that affects the ability to work, and may be psychologically devastating to the patient, and it requires major changes in lifestyle.
He warned of the rapid development of pulmonary hypertension, explaining that it needs early and accurate diagnosis, to obtain the best possible care and treatment, calling for a better understanding of the disease, and the impact it can have on the patient''s life.
Dr. Al-Damas revealed an awareness campaign that was launched on February 28, 2011, which is considered a day to raise awareness of this rare disease, with the aim of educating about pulmonary hypertension, and raising awareness of the dangers of the disease among the general public and the medical community, to a better environment for care and early diagnosis, and make the idea of more Research is a fact.
The regional director of Bayer Health Care Medicines in the Middle East, Muhammad Ziwar, said that the drug manufacturers have started to offer great competition to explore medicines for high blood pressure in the pulmonary artery, which would provide hope for patients with pulmonary hypertension.
